Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015

被引：88

作者：

Tanaka, Takaaki ^{[1
]}

Oishi, Tomohiro ^{[2
]}

Miyata, Ippei ^{[2
]}

Wakabayashi, Shoko ^{[2
]}

Kono, Mina ^{[2
]}

Ono, Sahoko ^{[2
]}

Kato, Atsushi ^{[2
]}

Fukuda, Yoko ^{[2
]}

Saito, Aki ^{[2
]}

Kondo, Eisuke ^{[2
]}

Teranishi, Hideto ^{[2
]}

Tanaka, Yuhei ^{[2
]}

Wakabayashi, Tokio ^{[2
]}

Akaike, Hiroto ^{[2
]}

Ogita, Satoko ^{[2
]}

Ohno, Naoki ^{[2
]}

Nakano, Takashi ^{[2
]}

Terada, Kihei ^{[2
]}

Ouchi, Kazunobu ^{[2
]}

机构：

[1] Kawasaki Med Sch, Dept Pediat, Okayama, Japan

[2] Kawasaki Med Sch, Okayama, Japan

来源：

EMERGING INFECTIOUS DISEASES | 2017年 / 23卷 / 10期

关键词：

STREPTOCOCCUS-PNEUMONIAE; SURVEILLANCE; SUSCEPTIBILITY;

D O I：

10.3201/eid2310.170106

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We evaluated isolates obtained from children with Mycoplasma pneumoniae infection throughout Japan during 2008-2015. The highest prevalence of macrolide-resistant M. pneumoniae was 81.6% in 2012, followed by 59.3% in 2014 and 43.6% in 2015. The prevalence of macrolide-resistant M. pneumoniae among children in Japan has decreased.

引用

页码：1703 / 1706

页数：4

共 50 条

[31] Evaluation of Lightmix Mycoplasma macrolide assay for detection of macrolide-resistant Mycoplasma pneumoniae in pneumonia patients
Wagner, K.
Imkamp, E.
Pires, V. P.
Keller, P. M.
CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (03) : 383.e5 - 383.e7
[32] Cluster of Macrolide-Resistant Mycoplasma pneumoniae Infections in Illinois in 2012
Tsai, Victoria
Pritzker, Bernard B.
Diaz, Maureen H.
Winchell, Jonas M.
Hicks, Lauri A.
Petrone, Brianna
Benitez, Alvaro
Wolff, Bernard J.
Soyemi, Kenneth L.
JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (11) : 3889 - 3892
[33] Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA
Lanata, Mariana M.
Wang, Huanyu
Everhart, Kathy
Moore-Clingenpeel, Melisa
Ramilo, Octavio
Leber, Amy
EMERGING INFECTIOUS DISEASES, 2021, 27 (06) : 1588 - 1597
[34] Prevalence of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients: a multicenter epidemiological study
Kawai, Y.
Kato, A.
Nishizawa, Y.
Kondo, E.
Saito, A.
Wakabayashi, T.
Akaike, H.
Tanaka, T.
Nakano, T.
Ouchi, K.
Miyashita, N.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S150 - S150
[35] Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae
Komatsu, Haruki
Tsunoda, Tomoyuki
Inui, Ayano
Sogo, Tsuyoshi
Fujisawa, Tomoo
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2014, 18 (03): : 294 - 299
[36] Macrolide-Resistant Mycoplasma pneumoniae in Children: Emphasis on the United States
Douvoyiannis, Miltiadis
CLINICAL PEDIATRICS, 2025,
[37] Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children
Lee, Hyunju
Yun, Ki Wook
Lee, Hoan Jong
Choi, Eun Hwa
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (01) : 23 - 34
[38] Infections Due to Macrolide-Resistant Mycoplasma pneumoniae: Now What?
Bebear, Cecile
CLINICAL INFECTIOUS DISEASES, 2012, 55 (12) : 1650 - 1651
[39] Macrolide-resistant Mycoplasma pneumoniae pneumonia in transplantation: Increasingly typical?
Eschenauer, Gregory A.
Xiao, Li
Waites, Ken B.
Crabb, Donna M.
Ratliff, Amy E.
Gandhi, Tejal N.
Riddell, James
Kaul, Daniel R.
TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (05)
[40] Antimicrobial and immunomodulatory effect of clarithromycin on macrolide-resistant Mycoplasma pneumoniae
Kurata, Satoshi
Taguchi, Haruhiko
Sasaki, Tsuguo
Fujioka, Yasunori
Kamiya, Shigeru
JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 59 (06) : 693 - 701

← 1 2 3 4 5 →